Category: 2021, No. 09

Current status and directions of vision rehabilitation in glaucoma

Authors: Huang Haishun,  Li Yiqing,  Zhuo Yehong DOI: 10.3760/cma.j.cn115989-20200119-00783 Published 2021-09-10 Cite asChin J Exp Ophthalmol, 2021, 39(9): 827-831. Abstract                              [View PDF] [Read Full Text] Glaucoma, the leading cause of irreversible visual impairment in the world, leads to visual function damage that seriously affects the […]

New diagnosis and treatment pattern for cataract based on artificial intelligence

Authors: Wang Ting,  Wang Ruixin,  Lin Haotian DOI: 10.3760/cma.j.cn115989-20200608-00405 Published 2021-09-10 Cite asChin J Exp Ophthalmol, 2021, 39(9): 832-836. Abstract                              [View PDF] [Read Full Text] With the increase in the aging of the global population, the prevalence of cataract has increased gradually, and cataract has […]

Research progress in the clinical features of reticular macular disease

Authors: Diao Yuyao,  Cheng Hao DOI: 10.3760/cma.j.cn115989-20190216-00055 Published 2021-09-10 Cite asChin J Exp Ophthalmol, 2021, 39(9): 837-840. Abstract                              [View PDF] [Read Full Text] Reticular macular disease (RMD) is a novel, independent macular disease closely related to age-related macular degeneration (AMD). It is currently available to […]